Tilray stock forecast: Breakout attempt gains traction on federal rescheduling of cannabis

Traders Union
All News
Stocks
Tilray climbs 4.37% on regulatory hopes

Highlights

Federal discussions on rescheduling cannabis to Schedule III could ease operating restrictions for Tilray stock and support broader market access.
Tilray stock gains from a product mix spanning cannabis, beverages, and wellness, which supports recent momentum.
Tilray stock is experiencing short- and medium-term bullish signals, with price seen fluctuating between $4.73 to $5.13 in the coming days.

Federal rescheduling debate and business diversity bolster investor optimism

The main catalyst for TLRY comes from ongoing federal discussions regarding the possible rescheduling of cannabis to Schedule III, as reported by Kalkinemedia. This regulatory development could ease restrictions on cannabis companies, supporting sentiment and bringing the potential for wider market access and improved funding conditions. Interest is further fueled by the company's diversified exposure to cannabis, beverages, and wellness products, contributing to current momentum.

Mixed oscillator signals persist as price faces MA-200 barrier

On the hourly chart, TLRY trades above the MA-20 at $4.77 and the MA-50 at $4.67, but remains below the MA-200 level of $6.97. The Ichimoku Kijun provides immediate support at $4.75. The MACD indicates a buy signal, while the ADX is neutral, showing momentum without a clear trend. RSI is at 54.5 in the buy zone, Stoch RSI signals a sell, and CCI reads neutral, resulting in mixed oscillator signals. Bull/Bear Power favors buyers intraday, whereas the Awesome Oscillator confirms ongoing bullish pressure.

Sideways consolidation likely unless resistance or support breaks

Over the coming days, TLRY is expected to fluctuate within a price band of $4.73 to $5.13, with a 65% probability of an upward move and a 35% chance of a downward correction. The baseline expectation is for TLRY to consolidate in a sideways corridor, while a break above resistance would open the way for further gains; conversely, a sustained move below immediate support could trigger a bearish scenario.

Anton Kharitonov, an analyst at Traders Union, sees short-term optimism in TLRY due to positive momentum above key moving averages and supportive news from cannabis rescheduling discussions. He believes mixed technical signals and resistance at the MA-200 limit immediate upside, while market sentiment has improved on regulatory hopes. Base case remains consolidation in the $4.73–$5.13 zone unless support breaks. "I remain cautious — as long as TLRY holds above immediate support, the risk/reward is balanced but upside needs confirmation."

Earlier, analysts noted that Tilray stock was locked in a range-bound pattern as conflicting technical signals limited directional conviction. The current analysis adds a new dimension with regulatory catalysts and persistent mixed momentum, making the reaction to any sustained move above immediate resistance a critical factor for near-term price action.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.